Topic search: NEUROLOGY

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Neurology Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 512-521	Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics Author(s): Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Nov/Dec 2023 Pg. 522-527	Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet Author(s): Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Sep/Oct 2023 Pg. 418-419	Ipratropium Bromide 0.05% Nasal Spray Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 317-318	Clobazam 5-mg/mL Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 323	Lamotrigine 1 mg/mL in SuspendIt Plus Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 329	Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 347-351	Chemical Stability of Epinephrine 10 mcg/mL Diluted in 0.9% Sodium Chloride and Stored in Polypropylene Syringes at 4 degrees C and 25 degrees C Author(s): Hook Roxanne, Neault Ashleigh, Scharrer Devan, Law Shirley, Walker Scott E, Ma Nathan H, Riss Vera
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 145	Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90% Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 149-151	Pilocarpine Hydrochloride 0.3% w/v Solution Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 51	Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 431	Methylcobalamin 2-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 235	Chloral Hydrate 70 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 237	Clobazam 1 mg/mL in Oral-Mix Suspension Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 239	Nitrazepam 1 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 110-115	The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report Author(s): Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 412	Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 417	Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 418	Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 427-430	Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Author(s): Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 258-262	Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Author(s): Odanaka Keita, Kojima Hiroki, Nakagawa Naoto
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 278-281	Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2 Author(s): Riepl Mike
Jul/Aug 2020 Pg. 314	Doxepin Hydrochloride 5% in Cetaphil Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 319	Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 321	Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 194-197	Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
May/Jun 2020 Pg. 224	Baclofen 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 233	Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 242-245	Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture Author(s): Ngim Kenley, Patel Jalpa
Mar/Apr 2020 Pg. 104-108	Low-dose Pilocarpine Spray to Treat Xerostomia Author(s): Zur Eyal
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 132	Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 138	Topiramate 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jan/Feb 2020 Pg. 56	Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 62	Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 63	Venlafaxine 15 mg/mL in Syrup Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 488	Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 495	Zonisamide 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 318	Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 320-323	Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2019 Pg. 234	Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 258-263	An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability Author(s): Reindel Kristin L, DeAngelis Michael J, Ferrara Alexander S, Conn Kelly M, Phillips Elizabeth M, Corigliano Anthony T, Zhao Fang
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Mar/Apr 2019 Pg. 113-119	Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Author(s): Zur Eyal
Mar/Apr 2019 Pg. 151	Perphenazine 0.5 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019 Pg. 167-175	Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure Author(s): Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 82-87	Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Author(s): Shakshuki Ayah, Agu Remigius U
Nov/Dec 2018 Pg. 492	Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 325	Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 335-339	Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
May/Jun 2018 Pg. 235	Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 240-246	Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Author(s): Khokhlova Kateryna O, Zdoryk Oleksandr A
Mar/Apr 2018 Pg. 146	Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 148	Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Sep/Oct 2017 Pg. 409	Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Jul/Aug 2017 Pg. 318	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 235	Meloxicam 1% Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Jan/Feb 2017 Pg. 65	Zonisamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 461-467	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Nov/Dec 2016 Pg. 506	Capsaicin 0.025% and Doxepin 3.3% Cream Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 512	Melatonin 2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 517-520	Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Author(s): Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Sep/Oct 2016 Pg. 406	Clobazam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 409	Levetiracetam 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 235	Zolpidem Tartrate 5-mg and 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 236-238	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration Author(s): Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 49	Aripiprazole 10-mg Oral Dissolving Tablets Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 511	Memantine Hydrochloride Capsules Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 268-270	Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Author(s): Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 161-166	Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Mar/Apr 2015 Pg. 167-173	Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Jan/Feb 2015 Pg. 67	Lidocaine Hydrochloride 4% Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 503	Tamsulosin Hydrochloride 0.2-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 414	Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 416	Sumatriptan Succinate 12-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 345-347	Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
May/Jun 2014 Pg. 236	Dibucaine 1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 239	Naproxen 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 241	Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Mar/Apr 2014 Pg. 142	Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 152-158	Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Author(s): Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Jan/Feb 2014 Pg. 64	Neostigmine Bromide 15-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 66	Phenobarbital 60-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 506	Metyrosine 250-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 507	Phenytoin Sodium 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 423	Terbutaline Sulfate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 335	Succinylcholine Chloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 344-346	Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Mar/Apr 2013 Pg. 145	Alcohol Dehydrated Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 146	Betahistine 16-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 70	Neostigmine Methylsulfate 0.5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 506	Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 507	Papaverine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 508	Valproate Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 509	Vercuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 513-515	Stability of Propranolol Hydrochloride in SyrSpend SF Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Sep/Oct 2012 Pg. 369-375	Medical Therapy for Acquired Urinary Incontinence in Dogs Author(s): Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Sep/Oct 2012 Pg. 422	Haloperidol 50-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 424	Methocarbamol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 427	Oxymorphone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Jul/Aug 2012 Pg. 334	Diphenhydramine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 335	Etomidate 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 338	Methyldopate Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 347-349	Stability of Gabapentin in SyrSpend SF Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
May/Jun 2012 Pg. 182-188	A Concise Discussion of Headache Types, Part 2: Migraine Author(s): Williams LaVonn A
May/Jun 2012 Pg. 196-205	Burning Mouth Syndrome: A Discussion of a Complex Pathology Author(s): Zur Eyal
May/Jun 2012 Pg. 238	Acetazolamide 100-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 244	Naloxone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 245	Orphenadrine Citrate 30-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 246	Prochlorperazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 162	Midazolam 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 163	Promethazine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 125-132	A Concise Discussion of Headache Types, Part 1 Author(s): Williams LaVonn A
Mar/Apr 2012 Pg. 156	Caffeine Citrate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 159	Glycopyrrolate 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 160	Labetalol Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 161	Lorazepam 4-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 170-173	Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method Author(s): Zhang Yang, Jiang Hongliang, Hutson Paul
Jan/Feb 2012 Pg. 82-85	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jan/Feb 2012 Pg. 69	Calculations Author(s): Stockton Shelly J
Jan/Feb 2012 Pg. 72	Magnesium Sulfate 10% Injection (0.8 mEq/mL) Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
Jul/Aug 2011 Pg. 337	Glycopyrrolate 0.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 343	Riboflavin 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 242	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 246	Melatonin 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 156	Acetylcysteine 1% or 10% Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 170-173	Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes Author(s): McCluskey Susan V, Lovely Jenna K
Jan/Feb 2011 Pg. 27-31	Goliath: Case Report on a Canine Case of Epilepsy Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
Jan/Feb 2011 Pg. 74-77	Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs Author(s): Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
Jan/Feb 2011 Pg. 81-84	Stability of Venlafaxine Immediate-Release Suspensions Author(s): Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 515	Bromazepam 2.5-mg/mL Drops Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 426	Rufinamide 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 340	Fenoldopam Mesylate Injection Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 243	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 156	Lamotrigine 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 21-25	Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010 Pg. 75	Trigger Point Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 10-13	Sleepless in America: Compounding with Melatonin Author(s): Wynn Tom, Rawlings Kate
Nov/Dec 2009 Pg. 498-505	Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Author(s): Bramwell Bethany L
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
Nov/Dec 2009 Pg. 560	Topiramate 6-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 572-573	Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Author(s): Parish Roy C
Sep/Oct 2009 Pg. 437	Zonisamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 438-439	Chemical Stability of Scopolamine Hydrobromide Nasal Solution Author(s): Gupta Vishnu D
Sep/Oct 2009 Pg. 445-446	Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Jul/Aug 2009 Pg. 340	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2009 Pg. 246	Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 249	Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 160	Tolterodine 2-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 398-401	Veterinary Compounding for Myasthenia Gravis Author(s): Davidson Gigi S
Nov/Dec 2008 Pg. 550-552	Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties Author(s): Donnelly Ronald F, Corman Celine
Jul/Aug 2008 Pg. 306-309	The Magic of Magnesium Author(s): Boomsma Diane
Jul/Aug 2008 Pg. 310-315	Progesterone and Traumatic Brain Injury: A Review of Literature Author(s): Williams LaVonn A, Mead Jay H
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008 Pg. 267	Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 274-275	Chemical Stability of Naltrexone Hydrochloride Injection Author(s): Gupta Vishnu D
May/Jun 2008 Pg. 182-190	Topical Treatment of Neuropathic Pain Author(s): Vadaurri Vince
Mar/Apr 2008 Pg. 146	Acyclovir 5% Topical Ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 150	Carbamazepine Topical Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 83-85	Room Temperature Stability of Injectable Succinylcholine Dichloride Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2007 Pg. 384-388	Equine Cushing's Disease: A Clinical Update Author(s): Bliss George
Sep/Oct 2007 Pg. 422	Ergonovine Maleate 0.2-mg/mL Injection, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 212-218	Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Author(s): McNulty Jack P
May/Jun 2007 Pg. 245	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 246	Isoproterenol Compound Elixir Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 249	Methylphenidate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 181-184	Transdermal Gel in the Treatment of Postoperative Pain Author(s): Alexander Kayla, Wynn Tom
May/Jun 2007 Pg. 187-192	Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Author(s): Vail Jane
May/Jun 2007 Pg. 200	Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Author(s): Fields Shannon W
May/Jun 2007 Pg. 202-211	Levorphanol for the Treatment of Severe Chronic Pain Author(s): McNulty Jack P
Mar/Apr 2007 Pg. 116-120	Challenges of Compounding for Patients on the Ketogenic Diet Author(s): McElhiney Linda F
Mar/Apr 2007 Pg. 131	Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Author(s): Fields Shannon W
Mar/Apr 2007 Pg. 160	Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 26-27	Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 70	Carbidopa 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 73	Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 75	Methyldopa 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 434-435	Ronidazole in the Treatment of Trichomonad Infections in Cats Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 456	Gabapentin 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 344-350	Migraine: A General Approach to Prevention and Treatment Author(s): Kennedy Bonnie M
Sep/Oct 2006 Pg. 351	Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches Author(s): Williams Steve D
Sep/Oct 2006 Pg. 387	Midazolam Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 388	Nitrazepam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 396-399	Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Author(s): Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
Jul/Aug 2006 Pg. 299	Adderall 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 318-319	Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free Author(s): Gupta Vishnu D
Jul/Aug 2006 Pg. 316-317	Stability of Memantine in an Extemporaneously Prepared Oral Liquid Author(s): Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E
May/Jun 2006 Pg. 220	Carvedilol 1.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 223	Lamotrigine 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 225	Mexiletine Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 159-160	PostScription: Treatment of Chronic Pain with Methadone or Levorphanol Author(s): McNulty Jack P
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Jan/Feb 2006 Pg. 66	Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 472	Alprazolam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 474	Clonazepam 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 484-486	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A
Sep/Oct 2005 Pg. 339-346	Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Author(s): Mishkan Emilyn S
Sep/Oct 2005 Pg. 349-352	Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 396-298	Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Author(s): Landry Christine, Forest Jean-Marc, Hildgen Patrice
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
Jan/Feb 2005 Pg. 62	Amitriptyline Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 64	Gabapentin 2-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 65	Guaifenesin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 69	Phenol 8% Injection Author(s): Allen Loyd V Jr